Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMade Tech Regulatory News (MTEC)

Share Price Information for Made Tech (MTEC)

Share Price is delayed by 15 minutes
Get Live Data
39.25    1.00 (2.61%)
Bid:
38.50
Ask:
40.00
Spread: 1.50 (3.896%)
Market Cap: £58.60m
MTEC Live PriceLast checked at - London Stock Exchange

Intraday Made Tech Share Chart

Directorate Change

7 Oct 2025 07:00

RNS Number : 2775C
Made Tech Group PLC
07 October 2025
 

7 October 2025

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

MADE TECH GROUP PLC

("Made Tech" or the "Group")

 

Directorate change

 

Made Tech Group plc, a leading provider of digital, data, and technology services to the UK public sector announces that Neil Elton has mutually agreed with the Board that he will step down from his role as Chief Financial Officer following his decision to leave the business to pursue other career opportunities.

 

Neil has a six month notice period and will assist the Board during this period to enable an orderly handover until such time as a successor has been appointed. The Board has commenced the search for a new CFO, and a further announcement will be made in due course.

Joanne Lake, Chair, said: "We are grateful for the contribution Neil has made since joining at the start of 2024, and we wish him well in his future endeavours. As we set out in the final results on 24 September, FY26 trading to date is in line with management expectations, and this remains the case. With a strong balance sheet, substantial cash reserves, disciplined cost control, and FY26 revenue already supported by our strong Contracted Backlog, Made Tech is well positioned to build on this momentum." Neil Elton, CFO, said: "It has been a great privilege to serve as CFO of Made Tech. I would like to thank all of my colleagues for their partnership and support. I look forward to seeing the business go from strength to strength."

 Enquiries:

 

Made Tech Group plc

Rory MacDonald, CEO

Neil Elton, CFO

Email: investor-relations@madetech.com

Canaccord Genuity Limited (Nominated Adviser & Broker)

Simon Bridges / Harry Gooden / Andrew Potts / Elizabeth Halley-Stott

Tel: +44 (0) 20 7523 8000

 

 

 

 

About Made Tech

 

Made Tech is a provider of digital, data and technology services, which enable central government, healthcare, local government organisations and other regulated industries to digitally transform.

 

The Group operates from three locations across the UK - London, Manchester, and Bristol.

 

More information is available at https://investors.madetech.com/.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZMGGNVRGKZM
12
Date   Source Headline
1st May 20266:14 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSMade Tech awarded £19m contract with the GDS
26th Feb 20267:00 amRNSAppointment of Chief Financial Officer
26th Feb 20267:00 amRNSInterim Results
10th Dec 20257:00 amRNSTrading Statement
25th Nov 20251:00 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSGrant of LTIP and SAYE options
11th Nov 202512:22 pmRNSResult of AGM
27th Oct 20252:35 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSNotice of AGM
7th Oct 20257:00 amRNSDirectorate Change
24th Sep 20257:00 amRNSFinal Results
3rd Sep 20255:02 pmRNSHolding(s) in Company
5th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
17th Jul 20257:00 amRNSGrant of Awards / PDMR Dealings
26th Jun 20257:01 amRNSDirectorate Change
26th Jun 20257:00 amRNSFY25 Trading Update
8th May 20257:00 amRNS-RChange of Registered Office
7th Apr 20257:00 amRNSContract Wins
5th Feb 20257:00 amRNSHalf Year Results
23rd Jan 20257:00 amRNSNotice of Half Year Results
15th Jan 20257:00 amRNSNon-Executive Director Board Changes
26th Nov 20247:00 amRNSLaunch of 2024 SAYE Scheme & Grant of SAYE options
20th Nov 20242:11 pmRNSResult of AGM
20th Nov 20247:00 amRNSAGM Statement
21st Oct 20247:00 amRNSNotice of AGM & Posting of Annual Report
10th Oct 20247:00 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSAudited Final Results 2024
16th Sep 20247:00 amRNSNew contract with the Department for Education
27th Jun 20247:00 amRNSFull Year Trading Update
1st May 20241:19 pmRNSDirector Share Purchase
23rd Apr 20243:47 pmRNSTR-1
22nd Apr 20247:00 amRNSMade Tech awarded £19.5m new contract with DLUHC
29th Feb 20247:00 amRNSTR-1
26th Feb 20249:09 amRNSHalf Year Results
26th Feb 20247:00 amRNSHalf Year Results
1st Feb 20247:00 amRNSTrading Update and Notice of Results
9th Jan 20247:00 amRNSAppointment of new CFO and Board Changes
17th Nov 20232:48 pmRNSDirector Share Purchase
30th Oct 20237:00 amRNSExercise of options and PDMR Dealing
26th Oct 20231:33 pmRNSResult of AGM
20th Sep 20233:55 pmRNSNotice of AGM and Posting of Annual Report 2023
13th Sep 20237:00 amRNSAudited Final Results 2023
6th Sep 20237:00 amRNSNotice of Results and Online Presentations
16th Aug 20235:26 pmRNSTR-1
25th Jul 20232:43 pmRNSGrant of LTIP Awards
5th Jul 20237:00 amRNSDirector Share Purchase
19th Jun 202310:03 amRNSTR-1
26th May 202312:38 pmRNSHolding(s) in Company
5th May 202312:56 pmRNSTR-1
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.